INTS

Intensity Therapeutics

Stock NASDAQ – Stock Market Prices, News & Analysis

Entreprise biopharmaceutique en phase de développement focalisée sur des traitements innovants contre le cancer via des thérapeutiques uniques.

$ 7.78
0.64 %

Intensity Therapeutics

$ 7.78
0.64 %
INTS

Entreprise biopharmaceutique en phase de développement focalisée sur des traitements innovants contre le cancer via des thérapeutiques uniques.

Price history of Intensity Therapeutics
Price history of Intensity Therapeutics

Performance & Momentum

6 Months 10.67 %
1 Year 85.96 %
3 Years 94.74 %
5 Years 94.74 %
Momentum
79

Similar stocks to Intensity Therapeutics

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone